RankingsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Raw

ALNYLAM PHARMACEUTICALS, INC.ALNY

Market cap
$56.9B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Product--------131673626628941,2411,646
Collaborations-------------546510
Royalty revenue-----------184192
Total revenues--------75220493--1,8282,248
Cost of goods sold--------22578115140268307
Cost of collaborations and royalties-----------25294217
Research and development10699871131902763823915056556557928831,0041,126
Selling, general and administrative--------382479588621771796976
Total operating costs and expenses--------8901,1591,3211,5531,8222,1102,425
Loss from operations-44-55-129-93-405-296-425-500-815-939-828-709-785-282-177
Interest expense--------------142
Interest income211-------122-96122
Other expense, net6-10-0206-341146-2-109-126-181
Loss on the extinguishment of debt-------------77--
Total other expense, net1-3131461495454-27-143-342-151-200
Loss before income taxes----92-401-290-410--761-885-856-852-1,127-434-377
Benefit from (provision for) income taxes1--11-3----113147-99
Net loss-44-58-106-89-360-290-410-491-761-886-858-853-1,131-440-278
Earnings Per Share, Basic------------7.2-9.3-3.52-2.18
Earnings Per Share, Diluted------------7.2-9.3-3.52-2.18
Net loss-44-58-106-89-360-290-410-491-761-886-858-853-1,131-440-278
Unrealized (loss) gain on marketable securities0-116431-44-31-3110-2-811-0
Foreign currency translation (loss) gain----------0-711-512-10
Defined benefit pension plans, net of tax---------40-1-221
Total other comprehensive (loss) income-----------10-1121-11
Comprehensive loss-44-59-90-85-331-334-448-492-760-889-865-842-1,143-419-289